Benfotiamine in Alzheimer's Disease: A Pilot Study
NCT02292238
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
71
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
Benfotiamine
Sponsor
Burke Medical Research Institute
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]